Skip to content

Opioids Drive Hep C to More than 2 Million in U.S.

Opioids Drive Hep C to More than 2 Million in U.S.

Nearly 2.4 million Americans are infected with the hepatitis C virus, the CDC says. Most cases can be traced to injection-drug use among younger adults addicted to heroin and other opioids. Adults under 40 have the highest rate of new infections. (Source: WebMD Health)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 10
See all stories on this topic

Rock Health report suggests digital health could tackle traditional addiction care’s biggest struggles

The report suggests technology could help address variability in care and boost addiction treatment enrollment.   (Source: mobihealthnews)
See all stories on this topic

Medical center lands biggest grant ever to treat patients

The Center for Addiction Treatment has been awarded $500,000 by the SL Gimbel Foundation, the largest grant for patient care operations ever received by Cincinnati ’s longest-serving addiction treatment center.

CAT will use the money to help cover the one-year cost of providing primary care services for 1,200 patients and mental health counseling for 520 patients at its West End facilities. 

See all stories on this topic

St. Charles-based addiction treatment provider sold to Texas chain

SpecialCare Hospital Management, a St. Charles-based provider of inpatient stabilization and withdrawal management services for those with drug or alcohol addiction and related health issues, has been acquired by BayMark Health Services.

Terms of the deal, announced Friday, weren’t disclosed.

SpecialCare currently provides the inpatient service for 46 acute care hospitals in 13 states, official
See all stories on this topic

Amid opioid concerns, FDA approves powerful painkiller

AcelRx Pharmaceuticals Inc. won its first Food and Drug Administration approval Friday of a restricted-use opioid delivery system, but the nation’s top drug regulator issued an atypical statement to assuage concerns about another highly addictive painkiller hitting the market.

Redwood City-based AcelRx’s (NASDAQ: ACRX) Dsuvia is a single tablet of the opioid sufentanil, pre-packaged inside a th
See all stories on this topic

Published inAddiction

Be First to Comment

Leave a Reply